Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/1/2025

Levothyroxine Pharmacokinetics and Clinical Implications

Pharmacokinetic Properties

  • The American College of Endocrinology recommends levothyroxine dosing once daily to maintain stable thyroid hormone levels throughout the day, due to its long half-life of approximately 7 days, allowing for steady-state concentrations to be achieved in 6-8 weeks 1

Clinical Implications of the Long Half-Life

Dose Adjustment Timing

  • The Endocrine Society suggests waiting a minimum of 6-8 weeks between dose adjustments to allow levothyroxine to reach steady state before assessing therapeutic response, as adjusting doses too frequently can lead to overtreatment or undertreatment 1
  • TSH levels should be rechecked 6-8 weeks after any dose change to properly evaluate the effect, according to clinical guidelines 1

Monitoring Schedule

  • During initial titration, TSH should be monitored every 6-8 weeks until the target range is achieved, and once stable, monitoring can be reduced to every 6-12 months or when symptoms change 1

Comparison with Other Hormones

  • The plasma half-life of levothyroxine is exceptionally long compared to other hormones, such as full-length parathyroid hormone (PTH), which has a half-life of only 2-4 minutes, making levothyroxine suitable for once-daily replacement therapy 2

REFERENCES

1

Initial Treatment for Elevated TSH [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025